Conditions: Acne Rosacea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 22
Healthy volunteers: no

Brief summary:
The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.

Detailed description:
Acne rosacea is a chronic inflammatory disease with different components including inflammatory lesions (papules/pustules), erythema and telangiectasia. Brimonidine 0.33% Gel primarily affects the erythematous components of rosacea. As such, combination treatment with a standard rosacea treatment, such as Finacea 15% Gel, may provide additional relief for the inflammatory component of rosacea.

Arms:
arm 1: Azelaic acid 15% to the face each AM followed 30 minutes later by Brimonidine 0.33%

Azelaic acid 15% to the face each PM arm 2: Brimonidine 0.33% Gel

Interventions: intervention 1: Azelaic acid 15% intervention 2: Brimonidine 0.33%
Intervention descriptions: intervention 1: Applied to the face each AM and PM intervention 2: Applied to the face each AM 30 minutes after the application of Azelaic acid 15%

Protocol document: